Why Pharma’s Digital Health Tools Miss the Mark
Originally published in Pharmaphorum, March 2026
Pharma has invested heavily in digital health over the past decade. Yet many tools struggle to move beyond pilots or sustain meaningful engagement.
The challenge isn’t innovation. It’s execution. When digital health initiatives operate outside brand strategy, clinical workflows, and clear value models, even well-designed solutions can lose relevance and stall.
In this latest perspective, we explore why these patterns persist and what leading organizations are doing differently—from aligning digital and brand teams to redefining ROI and designing solutions that fit real-world care pathways.
Read the article on Pharmaphorum, where digital health insiders share common traps to avoid and the lessons learned for success.
Read the full article.
Authors
Gregg Fisher, Managing Partner, The Stem – gfisher@thestem.com
David Dixon is a Lead Digital Health Strategy Consultant, The Stem
Category: Digital Health, Digital Transformation, Featured blog post, Innovation, Pharmaceutical & Biotechnology
Return to articles page
follow us on LinkedIn
Next post